BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/20/2024 7:07:14 AM | Browse: 34 | Download: 178
 |
Received |
|
2024-05-11 18:41 |
 |
Peer-Review Started |
|
2024-05-11 18:41 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-09-19 21:33 |
 |
Revised |
|
2024-10-03 20:05 |
 |
Second Decision |
|
2024-12-06 02:42 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-12-06 08:34 |
 |
Articles in Press |
|
2024-12-06 08:34 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-12-16 02:37 |
 |
Publish the Manuscript Online |
|
2024-12-20 07:07 |
ISSN |
2219-2808 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Pediatrics |
Manuscript Type |
Clinical Trials Study |
Article Title |
Autologous cord blood vs individualized supplements in autistic spectrum disorder: CORDUS study results
|
Manuscript Source |
Invited Manuscript |
All Author List |
Felician A Stancioiu, Raluca Bogdan, Bogdan Ivanescu and Radu Dumitrescu |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Felician A Stancioiu, MD, Department of Clinical Research, Bio-Forum Foundation, Splai Unirii Nr 8, Parter, Bucharest 040245, Bucuresti, Romania. felicians@bio-forum.net |
Key Words |
Autistic spectrum disorder; Cord blood; Stem cells; Neuroinflammation; Autologous stem cell treatment; Neuronal specific enolase |
Core Tip |
CORDUS clinical study aimed to find factors correlated to therapeutic efficacy in autistic spectrum disorder (ASD) by comparing sequential administration of autologous cord blood (ACB) and individualised supplements and testing both the ASD children and the ACB. High initial levels of inflammation markers (erythrocyte sedimentation rate, C-reactive protein, tumor necrosis factor-alpha, α-2 globulins) or ferritin, but not high initial levels of neuronal specific enolase (NSE), were correlated with little or no improvement after cord blood administration. In some patients NSE was lowered after ACB. In a few patients improvement on specific supplements was superior to cord blood. Further studies are needed for finding predictors of cord blood efficacy in ASD. |
Publish Date |
2024-12-20 07:07 |
Citation |
<p>Stancioiu FA, Bogdan R, Ivanescu B, Dumitrescu R. Autologous cord blood vs individualized supplements in autistic spectrum disorder: CORDUS study results. <i>World J Clin Pediatr</i> 2025; 14(1): 96643</p> |
URL |
https://www.wjgnet.com/2219-2808/full/v14/i1/96643.htm |
DOI |
https://dx.doi.org/10.5409/wjcp.v14.i1.96643 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345